Skip to main content

Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.

Publication ,  Journal Article
Siddiqi, TJ; Cherney, D; Siddiqui, HF; Jafar, TH; Januzzi, JL; Khan, MS; Levin, A; Marx, N; Rangaswami, J; Testani, J; Usman, MS; Wanner, C ...
Published in: Journal of the American Society of Nephrology : JASN
February 2025

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal of the American Society of Nephrology : JASN

DOI

EISSN

1533-3450

ISSN

1046-6673

Publication Date

February 2025

Volume

36

Issue

2

Start / End Page

242 / 255

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Siddiqi, T. J., Cherney, D., Siddiqui, H. F., Jafar, T. H., Januzzi, J. L., Khan, M. S., … Butler, J. (2025). Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. Journal of the American Society of Nephrology : JASN, 36(2), 242–255. https://doi.org/10.1681/asn.0000000000000491
Siddiqi, Tariq Jamal, David Cherney, Hasan Fareed Siddiqui, Tazeen H. Jafar, James L. Januzzi, Muhammad Shahzeb Khan, Adeera Levin, et al. “Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.Journal of the American Society of Nephrology : JASN 36, no. 2 (February 2025): 242–55. https://doi.org/10.1681/asn.0000000000000491.
Siddiqi TJ, Cherney D, Siddiqui HF, Jafar TH, Januzzi JL, Khan MS, et al. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. Journal of the American Society of Nephrology : JASN. 2025 Feb;36(2):242–55.
Siddiqi, Tariq Jamal, et al. “Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.Journal of the American Society of Nephrology : JASN, vol. 36, no. 2, Feb. 2025, pp. 242–55. Epmc, doi:10.1681/asn.0000000000000491.
Siddiqi TJ, Cherney D, Siddiqui HF, Jafar TH, Januzzi JL, Khan MS, Levin A, Marx N, Rangaswami J, Testani J, Usman MS, Wanner C, Zannad F, Butler J. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. Journal of the American Society of Nephrology : JASN. 2025 Feb;36(2):242–255.

Published In

Journal of the American Society of Nephrology : JASN

DOI

EISSN

1533-3450

ISSN

1046-6673

Publication Date

February 2025

Volume

36

Issue

2

Start / End Page

242 / 255

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences